As of May 25
| -0.26 / -11.40%|
The 5 analysts offering 12-month price forecasts for Genesis Healthcare Inc have a median target of 2.00, with a high estimate of 7.00 and a low estimate of 1.00. The median estimate represents a -0.99% decrease from the last price of 2.02.
The current consensus among 5 polled investment analysts is to Hold stock in Genesis Healthcare Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.